CD79A and neoplasm: To investigate changes in immune cell populations associated with histotripsy treatment, immunohistochemistry was performed for IBA-1 (pan macrophage marker), CD3 (T-cell marker), and CD79a (B-cell marker) on pretreatment samples and samples from the treated and untreated tumor following histotripsy treatment.